Showing results (1111-1120 of 1,221) with videos related to

Sort By:
Pageof 123
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 StudyKevin X Liu, Arlene Naranjo, Fan F Zhang, et al.
Annals of Neurology|May 11, 2019
Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapyJuliane Gust, Olivia C Finney, Daniel Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancerD Y Zang, B H Lee, H-C Park, et al.
The Oncologist|September 13, 2017
Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical TrialAreej El-Jawahri, Joseph A Greer, William F Pirl, et al.
Preventive Oncology & Epidemiology|August 18, 2025
CHAT-S Study Protocol: A randomized controlled trial of a health insurance literacy education program for young adult cancer survivorsMary Killela, Cindy A Turner, Amy Chevrier, et al.
British Journal of Cancer|January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trialMichael D Hogarty, David S Ziegler, Andrea Franson, et al.
JAMA Network Open|January 9, 2024
Patient-Reported Financial Burden of Treatment for Colon or Rectal CancerSheetal Kircher, Fenghai Duan, Na An, et al.
Journal of Pain and Symptom Management|January 2, 2025
Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical TrialsSarah N Price, Ju-Whei Lee, Ilana F Gareen, et al.
Frontiers in Immunology|July 4, 2018
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Frontiers in Immunology|July 27, 2018
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Pageof 123